Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Bristow

Showing results (11-20 of 240) with videos related to

Pageof 24
Sort By:
Circulation|August 1, 1990
The surgically denervated, transplanted human heartM R Bristow
Journal of the American College of Cardiology|October 1, 1993
Changes in myocardial and vascular receptors in heart failureM R Bristow
Lancet (London, England)|September 15, 1998
Why does the myocardium fail? Insights from basic scienceM R Bristow
The American Journal of Cardiology|March 25, 1993
Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agentsM R Bristow
Hospital Practice (Office Ed.)|December 1, 1982
Toxic cardiomyopathy due to doxorubicinM R Bristow
The American Journal of Cardiology|December 31, 1997
Mechanism of action of beta-blocking agents in heart failureM R Bristow
The New England Journal of Medicine|June 14, 1979
Testing for doxorubicin cardiotoxicityM R Bristow
The American Journal of Cardiology|April 25, 1986
Beta 2 receptors on myocardial cells in human ventricular myocardiumM R Bristow, R Ginsburg
Circulation|November 18, 2000
Congestive heart failure: fifty years of progressE Braunwald, M R Bristow
The American Journal of Cardiology|April 26, 1985
Rationale for beta-adrenergic blocking drugs in cardiomyopathyM B Fowler, M R Bristow
Pageof 24

Showing results (11-20 of 240) with videos related to

Sort By:
Pageof 24
Circulation|August 1, 1990
The surgically denervated, transplanted human heartM R Bristow
Journal of the American College of Cardiology|October 1, 1993
Changes in myocardial and vascular receptors in heart failureM R Bristow
Lancet (London, England)|September 15, 1998
Why does the myocardium fail? Insights from basic scienceM R Bristow
The American Journal of Cardiology|March 25, 1993
Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agentsM R Bristow
Hospital Practice (Office Ed.)|December 1, 1982
Toxic cardiomyopathy due to doxorubicinM R Bristow
The American Journal of Cardiology|December 31, 1997
Mechanism of action of beta-blocking agents in heart failureM R Bristow
The New England Journal of Medicine|June 14, 1979
Testing for doxorubicin cardiotoxicityM R Bristow
The American Journal of Cardiology|April 25, 1986
Beta 2 receptors on myocardial cells in human ventricular myocardiumM R Bristow, R Ginsburg
Circulation|November 18, 2000
Congestive heart failure: fifty years of progressE Braunwald, M R Bristow
The American Journal of Cardiology|April 26, 1985
Rationale for beta-adrenergic blocking drugs in cardiomyopathyM B Fowler, M R Bristow
Pageof 24